R Squared LTD Merus N.V. Transaction History
R Squared LTD
- $103 Billion
- Q4 2024
A detailed history of R Squared LTD transactions in Merus N.V. stock. As of the latest transaction made, R Squared LTD holds 60 shares of MRUS stock, worth $2,437. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60Holding current value
$2,437% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MRUS
# of Institutions
203Shares Held
62MCall Options Held
243KPut Options Held
300K-
Rtw Investments, LP New York, NY4.17MShares$169 Million3.32% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.41MShares$138 Million3.17% of portfolio
-
Commodore Capital LP New York, NY3.35MShares$136 Million14.22% of portfolio
-
Wellington Management Group LLP Boston, MA2.89MShares$117 Million0.03% of portfolio
-
Samlyn Capital, LLC New York, NY2.61MShares$106 Million2.1% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $1.86B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...